Renal National Clinical Network

The Renal National Clinical Network has been established under the National Clinical Network programme umbrella and takes the place of the National Renal Advisory Board (NRAB), which was disestablished in November 2023.  Read about the NRAB, including minutes from its final meeting on 01 November 2023.

Membership for the first Renal National Clinical Network strategic group has been confirmed. Members were selected based on their area of clinical expertise and speciality, experience and location, to ensure wide representation across the country.

The Network had its inaugural meeting on 20 February 2024 in Wellington.

The Network’s future meeting schedule and work programme will be published soon.

Strategic Group members

Name

Role

Location

Drew Henderson

Co-lead and Nephrologist

Waikato

Leanne Te Karu

Co-lead and prescribing pharmacist

Napier

Helen Eddington

Nephrologist

Tauranga

Sheree Godfrey

Renal Social Worker

Palmerston North

Joanna Dunlop

HOD Nephrologist

Auckland

Sue Tutty

GP Liaison

Auckland

Suetonia Green

Professor/SMO

Christchurch

Tania Huria

Director of Hauora Māori and Equity

North Canterbury

Sandy McLean-Cooper

Director of Nursing and Midwifery

Nelson

Lyn Lloyd

Advanced Practitioner Dietitian

Auckland

Robin Erickson

Clinical Lead

Paediatric Kidney Service

 

Chairpersons for five sub-groups have also been appointed with membership to be confirmed soon.

Subgroups and chairpersons

Sub-group

Name

Role

Location

Digital Infrastructure

 

Tina Sun

Nephrologist

Auckland

Data Quality & Performance

Andrew Salmon

Nephrologist

Auckland

MOC - Dialysis

Shaiju Thaikandy

Renal Service Manager

Hastings

MOC - CKD

Walaa Saweirs

Nephrologist

Whangārei

Whānau & Consumer

Whetumarama (Marama) Parore

Principle Advisor – Whaikaha – Ministry of Disabled People

Wellington

 

Terms of Reference for the Renal Network (PPTX, 117 KB).

The terms of reference are currently draft and being agreed. The final terms of reference will be published when they are confirmed.

High-level priorities

Written text in blue boxes outlining The Network’s high-level priorities Written text in blue boxes outlining The Network’s high-level priorities Written text in blue boxes outlining The Network’s high-level priorities
  • To devise a comprehensive model of care for dialysis – including reviewing national capacity/capability and models of delivery
  • To enable a cross-sectorial approach to develop clear pathways to optimise the identification of CKD and access to best practice/management
  • To partner with other Networks to deliver a holistic and joined up approach to the prevention of kidney disease
  • To ensure robust data and data infrastructure inform targeted care and deliver optional (optimal) patient outcomes

Principles

Image and text of Network principles  Image and text of Network principles  Image and text of Network principles

Meet our Co-leads

Leanne Te Karu

Leanne Te Karu

Ngāti Rangi, Te Ati Haunui-a-Pāpārangi Muaūpoko

Leanne has broad experience across Aotearoa New Zealand’s health and disability system, including in clinical settings, governance, research, strategy, and iwi development.

Clinically, Leanne works as Aotearoa’s first pharmacist prescriber, focusing on complex multimorbidity and unmet needs. She is committed to weaving the strands of clinical excellence, cultural safety and indigenous knowledge and values.

In addition to general practice/medical clinics, she works in marae settings alongside rongoā practitioners, including in the Waimarino among her whānau, to optimise medicine therapy. Medicines optimisation acknowledges that medicines have the potential to cure, control or prevent illness but that they can also cause adverse effects. The aim is to ensure optimal use, so the impacts of illnesses are reduced, and drug-related harms are avoided.

Leanne sits on New Zealand’s Medicines Adverse Reactions Committee and was a Ministerial Appointment to the PHARMAC Review Panel tasked with reviewing Pharmac and to make recommendations on ensuring that New Zealanders have the best health outcomes from medicines and in particular Māori and Pasifika.

Leanne co-founded Ngā Kaitiaki o Te Puna Rongoā o Aotearoa, the Māori Pharmacists’ Association, in 2003 as a network to support Māori pharmacists and to hold the pharmacy profession to deliver culturally safe care to Māori.

A highlight of the awards and recognition Leanne has received includes being inaugural recipient of the Primary Healthcare Clinical Pharmacist Award at the New Zealand Primary Healthcare | He Tohu Mauri Ora Awards.

Leanne is focused on indigenous peoples and understanding how health systems can best support those who are disadvantaged, arguing for a medicines environment from a solution-focused societal perspective with mātauranga at its core.

Drew Henderson

Drew Henderson

Drew has been a consultant nephrologist in Aotearoa and Scotland for more than 15 years and is currently Medical Director and consultant nephrologist at Waikato Hospital.

He was the first full time nephrologist at Hawke’s Bay hospital between 2007 and 2011 where he led the development of the business case for the Hawke’s Bay Hospital Renal Unit. In parallel, he developed a comprehensive multidisciplinary renal service with provision of in-centre and home dialysis training, vascular access and parathyroid surgery, plasma exchange and local transplant follow up.

Drew developed outreach services to Wairoa and collaborated with the local community to set up the Wairoa community dialysis house.

After six years in Scotland, Drew returned to Aotearoa in 2017 and took up his role as consultant nephrologist before becoming clinical lead in 2019 and then Medical Director Cancer, Chronic Conditions and Radiology in 2022 at Waikato Hospital.

He is the medical lead for the business case and design for the new kidney unit Te Pureoranga at Waikato Hospital. He has been a member of the National Renal Advisory Board (2021-2023), the National Renal Transplant Service Strategic Group (2020-2023) and currently a council member of the Australia New Zealand Society of Nephrology.

Drew is an advocate for improvement in health outcomes for Māori and Pacific peoples including development of clinical equity measures to drive improvement and has helped increased transplantation rates for Māori across Te Manawa Taki.

NCN home page

NRAB

Clinical Leadership

Kidney Health NZ

 

If you have any questions about the Renal National Clinical Network, please contact Programme Manager Helen De Vere.